News archive
Analyse the IPO Guide PILA PHARMA
Diabetes company with new treatment in sight.
Read the analysis (in Swedish) here
(21 june 2021)
“Hon går till börsen med framtidens diabetesläkemedel”
Article on PILA PHARMA AB out now on the Swedish online magazine Realtid (in Swedish)
(20 june 2021)
”PILA PHARMA AB med den tidligere Novo Nordisk-forsker Dorte X. Gram i spidsen er nu klar til at ringe med børsklokken på det svenske Nasdaq First North Growth Market i Stockholm.”
Feature article in the life science magazine MedWatch (in Danish) here
(16 june 2021)
”PILA PHARMA rustar bolaget inför en ny fas och accelererad utvecklingsresa”
Feature article in Dagens Industri appendix Invest Talks (in Swedish) here
(15 june 2021)
”Nu påbörjas resan mot framtidens diabetesläkemedel”
PILA PHARMA AB featured in an article on p. 19 in Dagens Industri appendix Hållbar Finans with focus on sustainable finance (in Swedish) here
(10 june 2021)
This publication about DANSK BIOTEK is distributed in Denmark with todays Berlingske.
Read about on page 12-13 and about my personal view on fundraising in Denmark vs Sweden on page 20! (in Danish) here
NY PILLE SKAL FORBEDRE LIVET FOR MILLIONER AF TYPE 2-DIABETIKERE (in Danish) here
NÅR BIOTEK-SUCCES KRÆVER DET BEDSTE FRA BÅDE DANMARK OG SVERIGE (in Danish) here
(19-May-2021)
We’ve been interviewed about our background and our intentions to list PILA PHARMA AB later this year.
Please, read the article by Biostock (in Swedish) here
(23-Apr-2021)
Video interview (in Swedish) with CEO Dorte X. Gram by ‘Invest Talks’
Watch the interview in Swedish here
(12-Mar-2021)
Development of a novel drug to treat diabetes.
Investor presentation by CEO Dorte X. Gram at the BioStock Life Science Summit 2020, Lund, Sweden.
Watch the presentation in English here
(17-Nov-2020)
The Malmö-based company Pila Pharma, which has a drug candidate for type 2 diabetes, will be listed on one of the Swedish stock exchanges in the second quarter of next year.
Read the article in Swedish here
(17-Nov-2020)
Pila Pharma has scheduled its arrival on the Swedish stock market for May next year with the goal of fetching SEK 50m for developing the firm’s diabetes tablet leading up to phase III.
An interview with CEO Dorte X. Gram by Medwatch, Denmark.
Read the article in English here
Read the article in Danish here
(17-Nov-2020)
Our Opinion and Concept Paper on the role of TRPV1 in diabetes published in Trends in Molecular Medicine.
Read the paper here
(November 2017)
Novo-forsker gjorde ph.d.-projekt til biotekselskab og forbereder nu fase 2-studie.
An interview with CEO Dorte X. Gram by Medwatch, Denmark.
Read the article in Danish here
(1 January 2019)
Om jag har rätt kan detta bli gigantisk.
An interview with CEO Dorte X. Gram by BioStock, Sweden.
Read the article in Swedish here
PILA PHARMA är klar med uppstartsfasen och flyttar ut från inkubatorn.
An interview with CEO Dorte X. Gram published by Medeon, Sweden.
Read the article in Swedish here
Nytt piller skal göra livet lättare för diabetiker – svensk bolag vill förändra sjukvården.
An interview with CEO Dorte X. Gram published in Veckans Affärer, Sweden.
Winning prize to PILA PHARMA at the Almi Invest pitch competition 2016, sponsored by Veckans Affärer.
Check out the resulting article here
Uppstickaren som vill ta plats i läkemedelsindustrin.
An interview with CEO Dorte X. Gram published in ‘DI Almedalen, Distributed with Dagens Industri, Sweden.
Read the article in Swedish here
We are proud to be on the cover of the June 2017 issue of Affärslivet Norden, Medicine and Science magazine that focuses on innovation.
The magazine was distributed with Svenska Dagbladet.
Read the article in Swedish here
“Min uppfinning kom och hämtade tillbaka mig”
Dr. Dorte X. Gram, CEO of PILA PHARMA was interviewed by Sydsvenskan, Sweden.
Read the article in Swedish here
After ten years of diabetes R&D at Novo Nordisk, Dorte X. Gram took her findings and work further to start something on her own. As founder and CEO of PILA PHARMA she hopes to bring a new oral anti-diabetic agent to the market.
Read the article here
Development of a novel drug to treat diabetes.
Investor presentation by CEO Dorte X. Gram at the BioStock Life Science Summit 2018, Lund, Sweden.
Watch the presentation in English here
(25-Oct-2018)
We’re very pleased to share PILA PHARMA AB‘s new Youtube channel.
The first film shows a guest lecture at Prague University in September 2017 where CEO Dorte X. Gram talked to students about starting up a biotech company.
Watch the video here
(04-Sep-2017)
At BioEurope Spring in Stockholm in April 2016 Dr. Dorte X. Gram, CEO of PILA PHARMA was interviewed by the organizers about the current status and our plans going forward.
Please find the links below:
partnering360.com
(08-Apr-2016)
PILA PHARMA yesterday won the title “Årets pitchare 2016” at the ALMI Invest Seed Day in Stockholm, Sweden!
The 1-min pitch competition was held amongst 17 selected out of ALMI Invests 400 portfolio companies.
(06-Dec-2016)
In order to maximise the chance of getting to the final, I chose to do an alternative type of pitch to describe the ALMI-PILA history as well as the content of the project (indirectly).
At the final I did ‘the usual stuff’ with market size, potential return of investment and potential exit value (potentially in the unicorn league).
I’m very proud that the audience yesterday selected me and PILA PHARMA as winner of the title ‘Årets pitchare 2016’ at the ALMI Invest Seed Day!
ALTERNATIVE PITCH by PILA PHARMA:
Tack Sverige för ett fantastisk inkubator och innovations system!
Tack Malmö för ett häftigt uppstarts och tillväxt miljö!
— Forza Malmö, eller hur, Per?
Tack Per Antonsson, ALMI Invest Syd, för att du inte tröttnade på min mejl-storm om min teori!
Tack Universum för att Per hade förmåga att förstå teorin och att inse hur STORT det skulle kunna bli om man kan bota diabetes genom att blokera chili-receptorn!
Tack ALMI Invest för att ni vågade satsa på min kostnads-effektiva plan om snabb klinisk bevis för min diabetes tablet – och sen exit!
Tack befintliga och kommande investerare för att ni inte bara vil tjäna masser med pengar men också vil göra något bra för samhället och vara med om att slå ihjäl det stora diabetes-monster!
Tack!
Past meetings
78th Scientific Sessions
Orlando, Florida
June 22 – 26, 2018
3rd Biotech Hanse
Stockholm, Sweden
June 14, 2018
The Future of Swedish & Danish Life Science
Lund, Sweden
March 22, 2018
Diabetes Samverkan Sverige
Malmö, Sweden
March 22, 2018
BIO-EUROPE SPRING
Amsterdam, The Netherlands
March 12-14, 2018
BOSTON BIOTECH CONFERENCE
EUROPE CEO
Amsterdam, The Netherlands
March 11, 2018
French-Swedish Life Science Day 2017
Paris, France
December 14, 2017
Nordea Markets
Copenhagen, Denmark
November 20, 2017
Nordea Markets
Medicon Valley Alliance
Annual Meeting 2017 – Health, Wealth And World Class
Copenhagen, Denmark
November 10, 2017
Medicon Valley Alliance
BIO-Europe
23RD Annual International
Partnering Conference
Berlin, Germany
November 6–8, 2017
Bio-Europe
Nordic Life Science Days
Malmö, Sweden — Copenhagen, Denmark
September 12-14, 2017
nlsdays.com
European Association for the Study of Diabetes
Lisboa, Portugal
September 11-15, 2017
easd.org
Dr. Dorte X. Gram has accepted to give a talk entitled: ‘If I’m right, this could be a really big thing! – daring to challenge status-quo in diabetes treatment’
Prague Summer School – Advances in Drug Discovery
September 4-8, 2017
Prague, Czech Republic
praguesummerschool.cz
San Diego, CA
June 9-13, 2017
the American Diabetes Association’s
77th Scientific Sessions
professional.diabetes.org
San Diego, CA
June 19-22, 2017
The BIO International Convention
convention.bio.org
BioEurope Spring 2017
March 20–22, 2017
CCIB Convention Centre, Barcelona Spain
ebdgroup.com
Next Big Thing, Financial hearing, 2016
Live webcast Next Big Thing from Moderna Museet, Stockholm, Sweden.
December 2nd 2016, 13.00 (UTC/GMT +1 hour)
Almi Invest Seed Day
5 december 2016, Stockholm, Sweden.
PILA PHARMA’s CEO, Dr. Dorte Gram was invited to participate in a company pitch competition amongst 15 of ALMI Invest’s 400 portfolio companies.
Eventregistrering.se
BIO-Europe.
November 7–9, 2016, Cologne, Germany.
- Lifestyle diseases and longevity
PILA PHARMA’s CEO, Dr. Dorte Gram was invited to participate as a key speaker in a panel discussion in:
Day: Monday
Date: November 7, 2016
Time: 16:00
Room: 2 on level 2 - PILA PHARMA’s company presentation:
Day: Tuesday
Date: November 8, 2016
Time: 17:15
Room: Rheinsaal 4 on level 2
BIO-Europe.com
French-Swedish Life Science Day 2016.
October 20, 2016 at the Swedish Embassy, 17 Rue Barbet de Jouy, in Paris.
French-Swedish Life Science Day.eu
Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry.
September 14-15, 2016, Stockholm, Sweden.
Nordic Life Science Days.com
Boehringer Partnering Day.
September 13, 2016, Stockholm, Sweden.
bipartnering.com
52nd EASD (European Association for the Study of Diabetes) Annual Meeting.
September 12-16, 2016, Munich, Germany.
easd.org
Anglo-Nordic Lifescience Conference XIII
May 19, 2016 London, United Kingdom
anglonordiclifescience.com
Dansk Bioteks Årsmøde
May 4, 2016 Copenhagen, Denmark
danskbiotek.dk
Bio-Europe Spring 2016
April 4-6 2016, Stockholm, Sweden
ebdgroup.com
10th Swiss-Scandinavian Bio-Business Seminar
February 10, 2016 at SIX Stock Exchange building in Zurich, Switzerland
b2match.eu